Marijuana Use in Children: An Update Focusing on Pediatric Tetrahydrocannabinol and Cannabidiol Use

Overview

Journal J Am Coll Emerg Physicians Open

Publisher Elsevier

Specialty Emergency Medicine

Date 2022 Jul 11

PMID 35813522

Authors

Michael J Stoner

Ann Dietrich

Samuel Hiu-Fung Lam

Jessica J Wall

Carmen Sulton

Emily Rose

Affiliations

Soon will be listed here.

Abstract

Cannabis is the most used recreational drug in the United States, and its use is increasing among children and adolescents. With the increase in legalized use, there have been increases in intentional and accidental cannabis exposure in the pediatric population. There is also minimized perceived risk. We review the current use of cannabis and its derivatives, the drug effects and clinical presentation, common misconceptions, pharmacology, and epidemiology. Finally, we review some long-term consequences of cannabis use.

Citing Articles

Medicinal Cannabis and the Intestinal Microbiome.

Vitetta L, Nation T, Oldfield D, Thomsen M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770543 PMC: 11678570. DOI: 10.3390/ph17121702.

Effectiveness of cannabis use and cannabis use disorder interventions: a European and international data synthesis.

Connor J, Manthey J, Hall W, Stjepanovic D Eur Arch Psychiatry Clin Neurosci. 2024; 275(2):327-339.

PMID: 38780801 DOI: 10.1007/s00406-024-01829-5.

Marijuana use in children: An update focusing on pediatric tetrahydrocannabinol and cannabidiol use.

Stoner M, Dietrich A, Lam S, Wall J, Sulton C, Rose E J Am Coll Emerg Physicians Open. 2022; 3(4):e12770.

PMID: 35813522 PMC: 9255894. DOI: 10.1002/emp2.12770.

References

McConachie S, Caputo R, Wilhelm S, Kale-Pradhan P . Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review. Ann Pharmacother. 2019; 53(11):1145-1152. DOI: 10.1177/1060028019852601. View

Broyd S, van Hell H, Beale C, Yucel M, Solowij N . Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. Biol Psychiatry. 2016; 79(7):557-67. DOI: 10.1016/j.biopsych.2015.12.002. View

Chow R, Valdez C, Chow N, Zhang D, Im J, Sodhi E . Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis. Support Care Cancer. 2020; 28(5):2095-2103. DOI: 10.1007/s00520-019-05280-4. View

Spindle T, Bonn-Miller M, Vandrey R . Changing landscape of cannabis: novel products, formulations, and methods of administration. Curr Opin Psychol. 2019; 30:98-102. PMC: 7041884. DOI: 10.1016/j.copsyc.2019.04.002. View

Golub V, Reddy D . Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. Adv Exp Med Biol. 2020; 1264:93-110. DOI: 10.1007/978-3-030-57369-0_7. View

Richards J . Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department. J Emerg Med. 2018; 54(3):354-363. DOI: 10.1016/j.jemermed.2017.12.010. View

Kosterman R, Bailey J, Guttmannova K, Jones T, Eisenberg N, Hill K . Marijuana Legalization and Parents' Attitudes, Use, and Parenting in Washington State. J Adolesc Health. 2016; 59(4):450-6. PMC: 5035605. DOI: 10.1016/j.jadohealth.2016.07.004. View

Cipriani F, Mancino A, Pulitano S, Piastra M, Conti G . A cannabinoid-intoxicated child treated with dexmedetomidine: a case report. J Med Case Rep. 2015; 9:152. PMC: 4490763. DOI: 10.1186/s13256-015-0636-2. View

Wang G, Hoyte C, Roosevelt G, Heard K . The Continued Impact of Marijuana Legalization on Unintentional Pediatric Exposures in Colorado. Clin Pediatr (Phila). 2018; 58(1):114-116. DOI: 10.1177/0009922818805206. View

10.

Ford T, Hayley A, Downey L, Parrott A . Cannabis: An Overview of its Adverse Acute and Chronic Effects and its Implications. Curr Drug Abuse Rev. 2017; 10(1):6-18. DOI: 10.2174/1874473710666170712113042. View

11.

Claudet I, Mouvier S, Labadie M, Manin C, Michard-Lenoir A, Eyer D . Unintentional Cannabis Intoxication in Toddlers. Pediatrics. 2017; 140(3). DOI: 10.1542/peds.2017-0017. View

12.

Greene M, Kelly J . The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation. J Addict Med. 2014; 8(5):359-67. PMC: 4176951. DOI: 10.1097/ADM.0000000000000064. View

13.

Lattanzi S, Trinka E, Russo E, Striano P, Citraro R, Silvestrini M . Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. Drugs Today (Barc). 2019; 55(3):177-196. DOI: 10.1358/dot.2019.55.3.2909248. View

14.

Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M . Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet. 2004; 363(9421):1579-88. DOI: 10.1016/S0140-6736(04)16200-4. View

15.

Bass J, Linz D . A Case of Toxicity from Cannabidiol Gummy Ingestion. Cureus. 2020; 12(4):e7688. PMC: 7233499. DOI: 10.7759/cureus.7688. View

16.

Marconi A, Di Forti M, Lewis C, Murray R, Vassos E . Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophr Bull. 2016; 42(5):1262-9. PMC: 4988731. DOI: 10.1093/schbul/sbw003. View

17.

Mustonen A, Niemela S, Nordstrom T, Murray G, Maki P, Jaaskelainen E . Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis. Br J Psychiatry. 2018; 212(4):227-233. DOI: 10.1192/bjp.2017.52. View

18.

Baron E . Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. Headache. 2015; 55(6):885-916. DOI: 10.1111/head.12570. View

19.

Cupo L, Plitman E, Guma E, Chakravarty M . A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis. Transl Psychiatry. 2021; 11(1):217. PMC: 8044224. DOI: 10.1038/s41398-021-01295-w. View

20.

Moore T, Zammit S, Lingford-Hughes A, Barnes T, Jones P, Burke M . Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007; 370(9584):319-28. DOI: 10.1016/S0140-6736(07)61162-3. View